Jan Jurgiel1, Krzysztof J Filipiak2, Łukasz Szarpak3, Miłosz Jaguszewski4, Jacek Smereka5, Tomasz Dzieciątkowski6. 1. Wroclaw Medical University, Poland; Erasmus+ Exchange Student at Nova Medical University, Lisbon, Portugal. 2. First Chair and Department of Cardiology, Medical University of Warsaw, Poland. Electronic address: krzysztof.filipiak@wum.edu.pl. 3. Lazarski Univeristy, Warsaw, Poland, Polish Society of Disaster Medicine, Warsaw, Poland. 4. First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland. 5. Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland. 6. Chair and Department of Medical Microbiology, Medical University of Warsaw, Poland.
The outbreak of COVID-19 – the global spread of the disease caused by SARS-CoV2 – took place at the end of 2019 in Wuhan, China [1]. After the infection of more than 120.000 people and the death of almost 5.000, the World Health Organization announced it as a global controllable pandemic
[2]. In April of 2020, the number of cases exceeded 2 million and the infection was spread over more than 180 countries [3], [4]. Humancoronaviruses (HCoVs) were on the origin of not only the current pandemic, but also of the SARS and MERS epidemics, which infected and took the lives of thousands of people [5], [6]. Virologic and genetical studies confirmed that bats have been transmission hosts for both of the viruses, which were further spread by civets and dromedaries [7], [8], [9]. Recent studies suggest that specific types of animals can be the source of different coronaviruses: bats for alpha- and beta-CoVs, avian for gamma- and delta-CoVs, and rodents for the ancestor of the beta-CoVs lineage A [10], [11], [12].The infection is not exclusive to wild animals and there are many known strains that affect livestock and pets [13]. Symptoms caused by coronaviruses depend on the type of strain; they may include gastrointestinal ailments (diarrhoea, vomiting, anorexia), respiratory ailments (dyspnoea, coughing, wheezing) and others. The animal origin of the novel coronavirus led to a discussion about the possible transmission of the disease by contact with pets. A common fear that raised even more after the confirmation of the SARS-CoV2 in a tiger in the Bronx zoological garden [14]. The World Health Organization faced those concerns stating the lack of evidence on the spreading of the novel coronavirus from pet animals to people [15].The empirical observations show that the presence of pets may have a positive impact on the course of COVID-19. Anecdotal evidence try to persuade that veterinary doctors are rarely affected with COVID-19. Doctor Sabina Olex-Condor, a Spanish physician in Madrid, suggested in an interview that the mild course is more frequent in patients owning pets (available at: www.vetnolimits.com; www.psy.pl; www.plus.gloswielkopolski.pl). The correlation between pet-ownership and the presence of a mild course of COVID-19 has not been found yet. In our study, we conducted a review of the literature, trying to establish a possible explanation to this observation. We suggest that the re-emerging contact with animal coronaviruses may lead to the stimulation of the immunological system, thus creating an effective response to SARS-CoV-2 infection.
The occurrence of the animal coronavirus in pets
The possible positive effect of pet-ownership can be considered if the presence of the animal coronaviruses is high across the pet population. Therefore, we studied the papers presenting the occurrence of the animal coronaviruses. In our analysis, we focus on dogs, due to two reasons: 1) they are the most common species taken as home pets [16], 2) canine coronaviruses can be transmitted easily to humans via droplets. Feline coronaviruses are also detected in cats, but their symptoms are mainly related to the gastrointestinal tract or are causative agent of uncommon and usually fatal, aberrant immune response to viral infection, but transmission animal-to-human is highly limited [17].Table 1
shows the detection rate in dogs. According to studies, the detection of canine respiratory coronavirus (CrCoV) is settled from 7.5% to 54.7%. Studies with the most prominent sample (Priestnal et al. 2006 and More et al. 2020) showed detection: 54.7% for North America, 36.0% for the United Kingdom, and 53.0% for New Zealand.
Table 1
Summary of studies detecting coronaviruses rate in dogs.
Author
Number of samples (n)
Detection rate
Method
Region
Priestnal et al. (2006) [18]
1000824
54.7%36.0%
Serology testing
North AmericaUK
More et al. (2020) [19]
1015
53.0%
Serology testing
New Zealand
Priestnal et al. (2007) [20]
490
23.3%
Serology testing
Italy
An et al. (2010) [21]
483
12.8%
Serology testing
Korea
Hielb et al. (2019) [22]
264
7.5%
Serology testing
Austria
Knesl et al. (2009) [23]
251
29.0%
Serology testing
New Zealand
Mitchell et al. (2017) [24]
247
47.0%7.7%
Serology testingmolecular testing
Europe
Decarao et al. (2007) [25]
215
32.0%
Serology testing
Italy
Schulz et al. (2014) [26]
151
9.8%
Molecular testing
Germany
Erles et al. (2003) [27]
119
37.0%
Molecular testing
UK
Erles et Brownlie [28](2005)
113
38.9%
Serology testing
UK
Sowman et al. (2018) [29]
93
50.5%
Serology testing
New Zealand
Wille et al. (2020) [30]
88
14.7%
Molecular testing
Sweden
Summary of studies detecting coronaviruses rate in dogs.Data show that the occurrence of CrCoV is high in dogs, which might suggest that humans who possess a pet can have more frequent contact with different types of canine coronaviruses. Since the infected pets may not have symptoms, the contact of owners with pathogens can be unnoticed [31].
Cross-reactivity and immune system mobilization
The human immunological system fights different viral infections by three pathways: 1) interferon-mediated, 2) cytotoxic cells-mediated, and 3) antibody-mediated [32]. On the first, interferons provide an effective immunological reaction by the activation of NK-cells and macrophages, repression of viral proteins production, and regulation of antigen presentation to T-cells. On the second path, cytotoxic cells can directly kill the host cells infected by the virus using specific receptors and enzymes, thus stopping further infection [33].The antibody-mediated ceasing of infection can be executed through different mechanisms: agglutination, phagocytosis or complement system degradation, but all of these are stimulated by the antibody opsonisation [32]. The effectiveness of this process is related to the specificity of the antibody – the capability of the antibody to discriminate between similar and dissimilar antigens. However, due to cross-reactivity, antibodies can respond to other antigen due to the resemblance of its structures [34]. Response to a similar antigen can lead to effective immunological protection as it was executed against the primary target. The cross-reactivity is related to the degree of the resemblance of the primary antigen to the other, for example: neutralizing antibodies against “old” SARS-CoV have moderate binding force to novel coronavirusSARS-CoV-2.The coronaviruses genome encodes for four structural and sixteen non-structural proteins, approximately [35], [36]. The spike proteins (S-protein) are the structural proteins that recognize and attach to ACE2 located on the cell membrane of the airways epithelia and lung parenchyma. In their study, Tilocca and colleagues sequenced the SARS-CoV-2 aminoacidic sequence and compared it to the sequences derived from the other animal coronaviruses [37]. The analysis showed that the resemblance of the whole sequence between SARS-CoV-2 and Canine Respiratory Coronavirus (CrCoV) is 36.39% (comparing the protein GI QHR63290 to QAY30030). However, further investigation of the epitope sequence shows the high homology: 57.14%, 80.00%, 83.33%, and 100.00% in CrCoV epitopes: 789–799, 754–764, 424–437, and 1139–1152, respectively. Based on the data, we suggest that recurrent contact with animal coronaviruses may lead to immunization. This effect was confirmed by the experimental studies. The investigation conducted by Lu and colleagues, showed that the nucleocapsid protein derived from CrCoV and expressed in E. coli displayed antigenic cross-reactivity with antisera against humancoronaviruses [38].Furthermore, Zhao and colleagues propose one more explanation to the protective effect of the contact with zoonoticcoronaviruses [39]. Cross-reactivity with T-cells can induce the immunological response. CD4+ memory T-cells on the epithelium of the airways can effectively produce interferon-gamma, which leads to activation of other cells and effective reaction.Thus, patients owning pets could have a mild course of the SARS-CoV-2 infection, which was observed in Spain. The recurrent contact with pathogens may work as immune-mobilization against SARS-CoV-2 in many different paths.
Conclusions
Canine respiratory coronaviruses occur often among dogs.Ownership of a pet can lead to the contact with dogs’ coronaviruses.Re-occurring contact with dogs’ coronaviruses might stimulate the human immunological system, and provide an effective response to SARS-COV-2.There is a need for further investigation on the correlation between pet ownership and the course of COVID-19. Such data, even obtain retrospectively, are worth to analyse.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Authors: Ndapewa Laudika Ithete; Samantha Stoffberg; Victor Max Corman; Veronika M Cottontail; Leigh Rosanne Richards; M Corrie Schoeman; Christian Drosten; Jan Felix Drexler; Wolfgang Preiser Journal: Emerg Infect Dis Date: 2013-10 Impact factor: 6.883
Authors: Christl A Donnelly; Matthew C Fisher; Christophe Fraser; Azra C Ghani; Steven Riley; Neil M Ferguson; Roy M Anderson Journal: Lancet Infect Dis Date: 2004-11 Impact factor: 25.071
Authors: Patrick C Y Woo; Susanna K P Lau; Kenneth S M Li; Rosana W S Poon; Beatrice H L Wong; Hoi-wah Tsoi; Bethanie C K Yip; Yi Huang; Kwok-hung Chan; Kwok-yung Yuen Journal: Virology Date: 2006-05-02 Impact factor: 3.616
Authors: Sina Salajegheh Tazerji; Phelipe Magalhães Duarte; Parastoo Rahimi; Fatemeh Shahabinejad; Santosh Dhakal; Yashpal Singh Malik; Awad A Shehata; Juan Lama; Jörn Klein; Muhammad Safdar; Md Tanvir Rahman; Krzysztof J Filipiak; Alfonso J Rodríguez-Morales; Md Abdus Sobur; Farrokhreza Kabir; Bita Vazir; Leonard Mboera; Marco Caporale; Md Saiful Islam; John H Amuasi; Rasha Gharieb; Paola Roncada; Sahar Musaad; Bruno Tilocca; Mohammad Kazem Koohi; Ali Taghipour; Ahmet Sait; Kannan Subbaram; Alireza Jahandideh; Pejman Mortazavi; Mohammad Amin Abedini; David A Hokey; Unarose Hogan; Mohamed N F Shaheen; Ahmed Elaswad; Mahmoud M Elhaig; Mohamed Fawzy Journal: J Transl Med Date: 2020-09-21 Impact factor: 5.531